Heart Rate as a Predictor of Mortality: The MATISS Project
Fulvia Seccareccia, MSc,
Fabio Pannozzo, MD,
Francesco Dima,
Anna Minoprio, MSc,
Antonio Menditto, MD,
Cinzia Lo Noce and
Simona Giampaoli, MD
Fulvia Seccareccia, Francesco Dima, Cinzia Lo Noce, and Simona Giampaoli are with the Laboratory of Epidemiology and Biostatistics, Istituto Superiore di Sanità, Rome, Italy. Fabio Pannozzo is with Health Unit LT4, Latina, Italy. Anna Minoprio and Antonio Menditto are with the Laboratory of Clinical Biochemistry, Istituto Superiore di Sanità.
Correspondence: Requests for reprints should be sent to Fulvia Seccareccia, MSc, Laboratory of Epidemiology and Biostatistics, Istituto Superiore di Sanità, Viale Regina Elena, 299, I-00161 Rome, Italy (e-mail: fulvias{at}iss.it).
Objectives. This study sought to verify the independent roleof heart rate in the prediction of all-cause, cardiovascular,and noncardiovascular mortality in a low-risk male population.
Methods. In an Italian population-based observational study,heart rate was measured in 2533 men, aged 40 to 69 years, between1984 and 1993. Data on cardiovascular risk factors were collectedaccording to standardized procedures. Vital status was updatedto December 1997.
Results. Of 2533 men followed up (representing 24 457 person-years),393 men died. Age-adjusted death rates for 5 heart rate levelsshowed increasing trends. The adjusted hazard rate ratios foreach heart rate increment were 1.52 (95% confidence interval[CI] = 1.29, 1.78) for all-cause mortality, 1.63 (95% CI = 1.26,2.10) for cardiovascular mortality, and 1.47 (95% CI = 1.19,1.80) for noncardiovascular mortality. Relative risks betweenextreme levels were more than 2-fold for all endpoints considered.
Conclusions. Heart rate is an independent predictor of cardiovascular,noncardiovascular, and total mortality in this Italian middle-agedmale population.
This article has been cited by other articles:
M. Biel, C. Wahl-Schott, S. Michalakis, and X. Zong Hyperpolarization-Activated Cation Channels: From Genes to Function
Physiol Rev,
July 1, 2009;
89(3):
847 - 885.
[Abstract][Full Text][PDF]
J.-C. Tardif Heart rate as a treatable cardiovascular risk factor
Br. Med. Bull.,
June 1, 2009;
90(1):
71 - 84.
[Abstract][Full Text][PDF]
A. Tverdal, V. Hjellvik, and R. Selmer Heart rate and mortality from cardiovascular causes: a 12 year follow-up study of 379 843 men and women aged 40-45 years
Eur. Heart J.,
November 2, 2008;
29(22):
2772 - 2781.
[Abstract][Full Text][PDF]
B. Mathew, L. Francis, A. Kayalar, and J. Cone Obesity: Effects on Cardiovascular Disease and its Diagnosis
J Am Board Fam Med,
November 1, 2008;
21(6):
562 - 568.
[Abstract][Full Text][PDF]
R. M. Carney, B. Steinmeyer, K. E. Freedland, J. A. Blumenthal, P. K. Stein, W. A. Steinhoff, W. B. Howells, L. F. Berkman, L. L. Watkins, S. M. Czajkowski, et al. Nighttime Heart Rate and Survival in Depressed Patients Post Acute Myocardial Infarction
Psychosom Med,
September 1, 2008;
70(7):
757 - 763.
[Abstract][Full Text][PDF]
J. S. Borer Heart rate: from risk marker to risk factor
Eur. Heart J. Suppl.,
August 1, 2008;
10(suppl_F):
F2 - F6.
[Abstract][Full Text][PDF]
J.-C. Tardif The pivotal role of heart rate in clinical practice: from atherosclerosis to acute coronary syndrome
Eur. Heart J. Suppl.,
August 1, 2008;
10(suppl_F):
F11 - F16.
[Abstract][Full Text][PDF]
J. L. Zamorano Heart rate management: a therapeutic goal throughout the cardiovascular continuum
Eur. Heart J. Suppl.,
August 1, 2008;
10(suppl_F):
F17 - F21.
[Abstract][Full Text][PDF]
M. Cucherat Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in post-myocardial infarction: a meta-regression of randomized clinical trials
Eur. Heart J.,
December 2, 2007;
28(24):
3012 - 3019.
[Abstract][Full Text][PDF]
S. Cook, M. Togni, M. C. Schaub, P. Wenaweser, and O. M. Hess High heart rate: a cardiovascular risk factor?
Eur. Heart J.,
October 2, 2006;
27(20):
2387 - 2393.
[Full Text][PDF]
A Black, L Murray, C Cardwell, G Davey Smith, and P McCarron Secular trends in heart rate in young adults, 1949 to 2004: analyses of cross sectional studies
Heart,
April 1, 2006;
92(4):
468 - 473.
[Abstract][Full Text][PDF]
K. P. Savonen, T. A. Lakka, J. A. Laukkanen, P. M. Halonen, T. H. Rauramaa, J. T. Salonen, and R. Rauramaa Heart rate response during exercise test and cardiovascular mortality in middle-aged men
Eur. Heart J.,
March 1, 2006;
27(5):
582 - 588.
[Abstract][Full Text][PDF]
P. Poirier, T. D. Giles, G. A. Bray, Y. Hong, J. S. Stern, F. X. Pi-Sunyer, and R. H. Eckel Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss: An Update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease From the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism
Circulation,
February 14, 2006;
113(6):
898 - 918.
[Abstract][Full Text][PDF]
H. A. Shaltout and A. A. Abdel-Rahman Mechanism of Fatty Acids Induced Suppression of Cardiovascular Reflexes in Rats
J. Pharmacol. Exp. Ther.,
September 1, 2005;
314(3):
1328 - 1337.
[Abstract][Full Text][PDF]
A. Diaz, M. G. Bourassa, M.-C. Guertin, and J.-C. Tardif Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease
Eur. Heart J.,
May 2, 2005;
26(10):
967 - 974.
[Abstract][Full Text][PDF]
R. M. Carney, K. E. Freedland, and R. C. Veith Depression, the Autonomic Nervous System, and Coronary Heart Disease
Psychosom Med,
May 1, 2005;
67(Supplement_1):
S29 - S33.
[Abstract][Full Text][PDF]
S. Klein, L. E. Burke, G. A. Bray, S. Blair, D. B. Allison, X. Pi-Sunyer, Y. Hong, and R. H. Eckel Clinical Implications of Obesity With Specific Focus on Cardiovascular Disease: A Statement for Professionals From the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: Endorsed by the American College of Cardiology Foundation
Circulation,
November 2, 2004;
110(18):
2952 - 2967.
[Abstract][Full Text][PDF]
S. R. Salpeter, T. M. Ormiston, and E. E. Salpeter Cardiovascular Effects of {beta}-Agonists in Patients With Asthma and COPD: A Meta-Analysis
Chest,
June 1, 2004;
125(6):
2309 - 2321.
[Abstract][Full Text][PDF]
K. Fox Ivabradine -- a selective and specific If inhibitor: efficacy and safety in stable angina
Eur. Heart J. Suppl.,
September 1, 2003;
5(suppl_G):
G36 - G45.
[Abstract][PDF]
N. Singh Diabetes, Heart Rate, and Mortality
Journal of Cardiovascular Pharmacology and Therapeutics,
June 1, 2002;
7(2):
117 - 129.
[Abstract][PDF]